助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   晚期胃腺癌 的翻译结果: 查询用时:0.026秒
图标索引 在分类学科中查询
所有学科
肿瘤学
更多类别查询

图标索引 历史查询
 

晚期胃腺癌
相关语句
  advanced gastric adenocarcinoma
     But when it came to the expense,LF+DDP regime was 43.5% as much as that in LF+L-OHP group. Conclusion The LF+DDP regimen must be preferable to treating advanced gastric adenocarcinoma,for it is inexpensive but effective.
     结论 LF +DDP是治疗晚期胃腺癌有效且低费用方案。
短句来源
  advanced gaster adenocarcinoma
     Comparative Study of Three Different Chemotherapies for Advanced Gaster Adenocarcinoma
     三组不同的联合化疗方案治疗晚期胃腺癌病例的比较
短句来源
     Methods The clinical data of cases with advanced gaster adenocarcinoma (1)epidoxorubicin plus cisplatin plus fluorouracil plus leucovorin (ECF, 26 cases),(2)fluorouracil plus doxorubicin plus methotrexate (FAMTx,25 cases), and (3)fluorouracil plus doxorubicin plus mitomycin (FAM,26 cases) were analysed.
     方法 对ECF方案、FAMTx方案、FAM方案治疗的 77例晚期胃腺癌病例的临床资料统计分析。 结果 ECF组有效率为 6 1.5 % (16 / 2 6 ) ,其中完全缓解 2例 ;
短句来源
  “晚期胃腺癌”译为未确定词的双语例句
     Method: Thirty-seven patients who was pathologically confirmed as advanced gastric cancer received chemotherapy of the regimen: Epirubicin 50mg/m2 Ⅳ 2h d1, Oxaliplatin 85mg/m2 Ⅳ 2h d1, Lecovorin (LV)200mg/m2 Ⅳ 2h d1-3,,5Fu 500mg/m2 Civ 22h d1-3 civ repeated, every 3 weeks for at least 3 cycles.
     方法:入选者为病理证实的晚期胃腺癌患者。 化疗方案:表阿霉素50mg/m2静脉注射,d1,澳沙利铂85mg/m2静脉滴注2小时,d1,甲酰四氢叶酸200mg/m2静脉滴注2小时,d1~3,5-FU500mg/m2持续静脉泵入22小时,d1~3,每三周重复,至少完成3个周期判效。
短句来源
     The expression of telomerase activity in primary gastric cancer increased with the decrease of degree of cancer differentiation and the increasing of deapth of invasion.
     晚期胃腺癌组织中端粒酶阳性率显著高于早期胃腺癌 (P <0 .0 1) ; 胃腺癌组织中端粒酶的表达与分化程度及浸润深度的差异均无显著性 (P >0 .0 5 )。
短句来源
     Telomerase positive expression in advanced stage gastric cancer was 93 3%,which was significiantly higher than that in early stage(66 6%)(P<0 05).
     4 0例癌旁正常黏膜组织中仅 2例呈阳性表达。 晚期胃腺癌组织中端粒酶阳性表达率显著高于早期胃腺癌 (P <0 0 5 )。
短句来源
  相似匹配句对
     Results of Total Gastrectomy in the Treatment of Adenocarcinoma of the Cardia in Advanced Stages
     全切除治疗晚期贲门腺癌的疗效
短句来源
     Adenocarcinoma arising from aberrant pancreas in the stomach
     来源异位胰腺的腺癌
短句来源
     Gemzar and advanced pancreatic carcinoma
     健择和晚期腺癌
短句来源
     Combined therapy in the management of advanced prostatic cancer
     晚期前列腺癌的综合治疗
短句来源
     A STUDY ON THE HISTOGENESIS IN GASTRIC MICRO ADENOCARCINOMA
     微小腺癌的组织发生研究
短句来源
查询“晚期胃腺癌”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
为了更好的帮助您理解掌握查询词或其译词在地道英语中的实际用法,我们为您准备了出自英文原文的大量英语例句,供您参考。
  advanced gastric adenocarcinoma
Paclitaxel, carboplatin, and oral etoposide in advanced gastric adenocarcinoma
      
Fourteen patients with advanced gastric adenocarcinoma were treated with paclitaxel 200 mg/m2 iv, carboplatin AUC-6 iv on d 1, and oral etoposide 50 mg/d alternating with 100 mg/d on d 1-10.
      
Thirty-three evaluable patients with advanced gastric adenocarcinoma were treated with a combination of 5-fluorouracil, adriamycin, and mitomycin C (FAM).
      
Sequential moderate-dose methotrexate and 5-fluorouracil in advanced gastric adenocarcinoma
      
A total of 23 patients with advanced gastric adenocarcinoma were treated with a combination of moderate-dose methotrexate (MDMTX), 250 mg/m2 i.v., with folinic acid rescue and 5-fluorouracil (5-FU) 600 mg/m2 i.v.
      
更多          


Objective To compare the efficacy and toxicity of three different chemotherapies for advanced gaster adenocarcinoma. Methods The clinical data of cases with advanced gaster adenocarcinoma (1)epidoxorubicin plus cisplatin plus fluorouracil plus leucovorin (ECF, 26 cases),(2)fluorouracil plus doxorubicin plus methotrexate (FAMTx,25 cases), and (3)fluorouracil plus doxorubicin plus mitomycin (FAM,26 cases) were analysed. Results The response rate was 61.5% in patients treated with ECF ,52% in those...

Objective To compare the efficacy and toxicity of three different chemotherapies for advanced gaster adenocarcinoma. Methods The clinical data of cases with advanced gaster adenocarcinoma (1)epidoxorubicin plus cisplatin plus fluorouracil plus leucovorin (ECF, 26 cases),(2)fluorouracil plus doxorubicin plus methotrexate (FAMTx,25 cases), and (3)fluorouracil plus doxorubicin plus mitomycin (FAM,26 cases) were analysed. Results The response rate was 61.5% in patients treated with ECF ,52% in those treated with FAMTx,and 34.2% in those treated with FAM respectively.The major toxic reactions in the three groups were tolerable myelo-supprescion ,renal insufficiency, hair loss and mucous membrane inflammation. Conclusion ECF and FAMTx are effective and safe chemotherapy for the treatment of advanced gaster adenocarcinoma.

目的 比较三组不同的联合化疗方案对晚期胃癌的疗效和毒性。方法 对ECF方案、FAMTx方案、FAM方案治疗的 77例晚期胃腺癌病例的临床资料统计分析。结果 ECF组有效率为 6 1.5 % (16 / 2 6 ) ,其中完全缓解 2例 ;FAMTx组有效率为 5 2 % (13/ 2 5 ) ,其中完全缓解 1例 ;FAM组有效率为 34.2 % (9/ 2 6 )。毒副作用主要为骨髓抑制、肾功能不全、脱发及粘膜炎。结论 ECF及FAMTx方案为治疗晚期胃腺癌的较为安全而有效的治疗方案

To study the relationship between the expression of telomerase activity in human gastric cancer and the development of gastic cancer, telomerase activity in 45 samples of primary gastric cancer and 40 samples of "normal" gastric tissues was examined using IN SITUHYBRIDIZATION.Results showed that telomerase activity was positive in 38 of 45 gastric cancer tissues. Telomerase activity was 93.3% in advanced stage gastric cancer, which was significiantly higher than that in early stage (66.6%)(P< 0.05 ).40 samples...

To study the relationship between the expression of telomerase activity in human gastric cancer and the development of gastic cancer, telomerase activity in 45 samples of primary gastric cancer and 40 samples of "normal" gastric tissues was examined using IN SITUHYBRIDIZATION.Results showed that telomerase activity was positive in 38 of 45 gastric cancer tissues. Telomerase activity was 93.3% in advanced stage gastric cancer, which was significiantly higher than that in early stage (66.6%)(P< 0.05 ).40 samples of normal tissue surounding the cancer,2 sampels were merely positive telomerase activity expression.The expression of telomerase activity in primary gastric cancer increased with the decrease of degree of cancer differentiation and the increasing of deapth of invasion.The results indicated that telomerase activity in advanced stage gastric cancer was higher than that in early stage gastric cancer, which suggest telomerase may majorly occur as a late event of cancer progression.

为探讨胃腺癌组织中端粒酶的活性与胃癌病程进展的关系 ,采用端粒酶原位分子杂交检测法对 45例原发性胃腺癌及 40例癌旁正常胃粘膜组织中端粒酶活性进行原位检测。结果 45例原发性胃腺癌组织中 ,38例端粒酶呈阳性表达 ,其中早期胃癌阳性率为 6 6 .6 % ,中晚期为 93.3% ;40例癌旁正常胃粘膜组织中仅 2例呈阳性表达 ;晚期胃腺癌组织中端粒酶阳性率显著高于早期胃腺癌 (P <0 .0 1) ;胃腺癌组织中端粒酶的表达与分化程度及浸润深度的差异均无显著性 (P >0 .0 5 )。研究表明 ,虽然胃腺癌组织中端粒酶的表达与肿瘤分化程度及浸润深度无关 ,但中晚期胃腺癌中的表达水平高于早期的事实 ,提示端粒酶的高表达是胃癌发生发展过程中的中晚期事件。

Objective To study the relationship between the expression of telomerase activity in human gastric cancer and the development of gastic cancer.Methods Telomerase activity in 45 samples from primary gastric cancer and 40 samples of "normal" gastric tissues was examined using in situ hybridization technique.Results Telomerase activity was positive in 38 of 45 gastric cancer tissues.Telomerase positive expression in advanced stage gastric cancer was 93 3%,which was significiantly higher than that in early stage(66...

Objective To study the relationship between the expression of telomerase activity in human gastric cancer and the development of gastic cancer.Methods Telomerase activity in 45 samples from primary gastric cancer and 40 samples of "normal" gastric tissues was examined using in situ hybridization technique.Results Telomerase activity was positive in 38 of 45 gastric cancer tissues.Telomerase positive expression in advanced stage gastric cancer was 93 3%,which was significiantly higher than that in early stage(66 6%)(P<0 05).The expression of telomerase was enhanced with decline of cancer differentiation degree and the deepen of invasion depht.Conclusions Telomerase activity in advanced stage gastric cancer was higher than that in early stage gastric cancer,which suggests that the overexpression of telomerase may occur as a late event of gastric cancer progression.

目的 探讨胃腺癌组织中端粒酶的活性与胃癌进展的关系。方法 采用端粒酶原位分子杂交检测法对 4 5例原发性胃腺癌及 4 0例癌旁正常黏膜组织中端粒酶活性进行原位检测。结果  4 5例原发性胃腺癌组织中 ,38例端粒酶呈阳性表达 ,其中早期胃癌阳性率为 6 6 6 % ,中晚期为 93 3%。 4 0例癌旁正常黏膜组织中仅 2例呈阳性表达。晚期胃腺癌组织中端粒酶阳性表达率显著高于早期胃腺癌 (P <0 0 5 )。虽然胃腺组织中端粒酶的表达随分化程度的降低与浸润深度的增加而增强 ,但其表达上的差异均无显著性 (P均 >0 0 5 )。结论 虽然胃腺癌组织中端粒酶的表达与肿瘤分化程度及浸润深度无关 ,但中晚期胃腺癌中的表达水平高于早期胃癌的事实 ,提示端粒酶的高表达是胃癌发生发展过程中的中晚期事件

 
<< 更多相关文摘    
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关晚期胃腺癌的内容
在知识搜索中查有关晚期胃腺癌的内容
在数字搜索中查有关晚期胃腺癌的内容
在概念知识元中查有关晚期胃腺癌的内容
在学术趋势中查有关晚期胃腺癌的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社